Skip to content

Total Assets at other companies

Bristol-Myers Squibb logo
Bristol-Myers SquibbBMY
$86.48B-6.4%
Eli Lilly logo
Eli LillyLLY
$116.58B+30.4%
Pfizer logo
PfizerPFE
$207.62B-0.2%
Amgen logo
AmgenAMGN
$92.5B+3.5%
Regeneron Pharmaceuticals logo
Regeneron PharmaceuticalsREGN
$40.87B+8.9%
Biogen logo
BiogenBIIB
$29.48B+5.2%

Other financials

Income statement

See full
Revenue$25.6M-8.0%
Operating income-$34.6M-25.8%
Net income-$52.9M-34.5%
EPS (diluted)-$1.84-43.8%

Balance sheet

See full
Cash & equivalents$248.5M+152%
Total debt$13.6K-99.9%
Total equity$12.7M-62.5%

Cash flow

See full
Operating cash flow-$25.9M-142%
CapEx$17.0K-51.4%
Free cash flow-$25.9M-142%

Valuation

See full
Market cap$1.73B+180%
Enterprise value$1.48B+176%
P/S7.4×+1.9×

Profitability

See full
Operating margin17.6%+9.6pp
Net margin-49.9%-22.6pp
FCF margin1.9%+1.0pp

Returns & leverage

See full
Return on equity-343.8%-1,012pp
Debt / equity-0.5×
Current ratio7.6×-0.7×

Where this comes from

Reported directly by AnaptysBio, Inc. in its filing.

Tagged under the XBRL concept us-gaap:Assets.

The official record: AnaptysBio, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about AnaptysBio, Inc.'s total assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is AnaptysBio, Inc.'s total assets?
AnaptysBio, Inc. (ANAB) reported total assets of $329.68M in Q1 2026.
How has AnaptysBio, Inc.'s total assets changed year-over-year?
AnaptysBio, Inc.'s total assets decreased by 21.9% year-over-year, from $422.05M to $329.68M.
What is the long-term trend for AnaptysBio, Inc.'s total assets?
Over 5 years (2020 to 2025), AnaptysBio, Inc.'s total assets has grown at a -2.6% compound annual growth rate (CAGR), from $416.55M to $364.4M.
What does total assets mean?
The sum of everything the company owns — current assets, property, investments, goodwill, intangibles, and all other assets.